M. Grigoriev et al., INHIBITION OF GENE-EXPRESSION BY TRIPLE HELIX-DIRECTED DNA CROSS-LINKING AT SPECIFIC SITES, Proceedings of the National Academy of Sciences of the United Statesof America, 90(8), 1993, pp. 3501-3505
Synthetic oligodeoxynucleotides represent promising tools for gene inh
ibition in live systems. Triple helix-forming oligonucleotides, which
bind to double-stranded DNA, are of special interest since they are ta
rgeted to the gene itself rather than to its mRNA product, as in the a
ntisense strategy. Triple helix-forming oligonucleotides can be couple
d to DNA-modifying agents and used to introduce modifications in the D
NA target in a highly sequence-specific manner. We have recently desig
ned psoralen-oligonucleotide conjugates, which, upon binding to double
-stranded DNA sequences via triple helix formation, may be cross-linke
d in vitro to both strands of the DNA following UV irradiation. A psor
alen-oligonucleotide conjugate was targeted to the promoter of the alp
ha subunit of the interleukin 2 receptor (IL-2Ralpaha) gene. The tripl
e helix site overlaps the binding site for the transcription factor NF
-kappaB, which activates transcription from the IL-2Ralpha promoter. A
fter UV irradiation, the oligonucleotide conjugate becomes crosslinked
to the target site and inhibits transcription of reporter plasmids tr
ansfected in live cells. Inhibition is observed when UV-induced cross-
linking occurs both in vitro (before transfection) and in vivo (after
transfection). We directly demonstrate that this inhibitory effect is
due to triple helix formation at the target site, since a mutant of th
e promoter, to which oligonucleotide binding was inhibited, was not af
fected by the psoralen-oligonucleotide conjugate after UV irradiation.
In addition, we demonstrate that site-specific cross-linking upstream
of the promoter has no effect on transcription.